Published in
Esmo Open, Esmo Open, 4(9), p. 102386, 2024
DOI: 10.1016/j.esmoop.2024.102386
Endocrine Abstracts, 2023
Links
Tools
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-Differentiated Neuroendocrine Tumors
Journal article published in 2023 by
Mph Taymeyah Al-Toubah 
,
M. J. Schell,
Md Brian Morse ,
Md Mintallah Haider,
Pa Tiffany Valone,
Md Jonathan Strosberg
,
M. J. Schell,
Md Brian Morse ,
Md Mintallah Haider,
Pa Tiffany Valone,
Md Jonathan Strosberg
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 